| Literature DB >> 21197386 |
Abstract
Myostatin is a member of the transforming growth factor β superfamily of secreted growth factors that negatively regulates skeletal muscle size. Mice null for the myostatin gene have a dramatically increased mass of individual muscles, reduced adiposity, increased insulin sensitivity, and resistance to obesity. Myostatin inhibition in adult mice also increases muscle mass which raises the possibility that anti-myostatin therapy could be a useful approach for treating diseases such as obesity or diabetes in addition to muscle wasting diseases. In this review I will describe the present state of our understanding of the role of myostatin and the closely related growth factor growth/differentiation factor 11 on metabolism.Entities:
Year: 2010 PMID: 21197386 PMCID: PMC3011861 DOI: 10.2174/187152210793663810
Source DB: PubMed Journal: Immunol Endocr Metab Agents Med Chem ISSN: 1871-5222